RNA N4-acetylcytidine Modification and Its Role in Health and Diseases

Overview

Journal MedComm (2020)

Specialty Health Services

Date 2025 Jan 7

PMID 39764566

Authors

Qiang Wang

Yixiao Yuan

Qiang Zhou

Yingdong Jia

Jing Liu

GuangJun Xiao

Chunhong Li

Xiulin Jiang

Affiliations

Soon will be listed here.

Abstract

N4-acetylcytidine (ac4C) modification is a crucial RNA modification widely present in eukaryotic RNA. Previous studies have demonstrated that ac4C plays a pivotal role in viral infections. Despite numerous studies highlighting the strong correlation between ac4C modification and cancer progression, its detailed roles and molecular mechanisms in normal physiological processes and cancer progression remain incompletely understood. This review first outlines the key regulatory enzyme mediating ac4C modification, N-acetyltransferase 10 (NAT10), including its critical roles in regulating RNA stability, transcriptional efficiency, and translational fidelity. Additionally, it systematically summarizes the essential functions and mechanisms of ac4C modification in normal biological processes, including stem cell fate determination, spermatogenesis and oogenesis, embryonic development, cellular senescence, and bone remodeling. Furthermore, this review delves into the central roles and molecular mechanisms of ac4C modification in regulating malignant proliferation, cell cycle arrest, EMT, drug resistance, cell death, cancer metabolism, and tumor immunotherapy. It also emphasizes the potential of NAT10 as a prognostic biomarker and its therapeutic potential as a target for disease treatment. In summary, this review clarifies the multifaceted roles of ac4C modification in both health and disease and explores NAT10-targeted therapies with the aim of advancing cancer research and improving patient outcomes.

References

Tsai K, Vasudevan A, Martinez Campos C, Emery A, Swanstrom R, Cullen B . Acetylation of Cytidine Residues Boosts HIV-1 Gene Expression by Increasing Viral RNA Stability. Cell Host Microbe. 2020; 28(2):306-312.e6. PMC: 7429276. DOI: 10.1016/j.chom.2020.05.011. View

Debnath J, Gammoh N, Ryan K . Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023; 24(8):560-575. PMC: 9980873. DOI: 10.1038/s41580-023-00585-z. View

Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L . Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metab. 2022; 34(9):1312-1324.e6. DOI: 10.1016/j.cmet.2022.08.002. View

Balmus G, Larrieu D, Barros A, Collins C, Abrudan M, Demir M . Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun. 2018; 9(1):1700. PMC: 5923383. DOI: 10.1038/s41467-018-03770-3. View

Szeto G, Finley S . Integrative Approaches to Cancer Immunotherapy. Trends Cancer. 2019; 5(7):400-410. PMC: 7467854. DOI: 10.1016/j.trecan.2019.05.010. View

Kawai G, Ue H, Yasuda M, Sakamoto K, Hashizume T, McCloskey J . Relation between functions and conformational characteristics of modified nucleosides found in tRNAs. Nucleic Acids Symp Ser. 1991; (25):49-50. View

Furtado C, Luciano M, da Silva Santos R, Furtado G, Moraes M, Pessoa C . Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics. 2019; 14(12):1164-1176. PMC: 6791710. DOI: 10.1080/15592294.2019.1640546. View

Liu X, Liu X, Zhuo C, Shen J, Lu K, Sha M . NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway. Discov Med. 2023; 35(179):936-945. DOI: 10.24976/Discov.Med.202335179.89. View

Yu X, Li S, Yao Z, Xu J, Zheng C, Liu Z . N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing. Oncogene. 2023; 42(14):1101-1116. DOI: 10.1038/s41388-023-02628-3. View

10.

Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J . NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022; 12(5):e738. PMC: 9076013. DOI: 10.1002/ctm2.738. View

11.

Rossant J, Tam P . Early human embryonic development: Blastocyst formation to gastrulation. Dev Cell. 2022; 57(2):152-165. DOI: 10.1016/j.devcel.2021.12.022. View

12.

Peterman E, Prekeris R . The postmitotic midbody: Regulating polarity, stemness, and proliferation. J Cell Biol. 2019; 218(12):3903-3911. PMC: 6891101. DOI: 10.1083/jcb.201906148. View

13.

Sas-Chen A, Thomas J, Matzov D, Taoka M, Nance K, Nir R . Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature. 2020; 583(7817):638-643. PMC: 8130014. DOI: 10.1038/s41586-020-2418-2. View

14.

Zhang W, Gao J, Fan L, Wang J, He B, Wang Y . ac4C acetylation regulates mRNA stability and translation efficiency in osteosarcoma. Heliyon. 2023; 9(6):e17103. PMC: 10361233. DOI: 10.1016/j.heliyon.2023.e17103. View

15.

Ikeuchi Y, Kitahara K, Suzuki T . The RNA acetyltransferase driven by ATP hydrolysis synthesizes N4-acetylcytidine of tRNA anticodon. EMBO J. 2008; 27(16):2194-203. PMC: 2500205. DOI: 10.1038/emboj.2008.154. View

16.

Gao J, Xu P, Wang F, Zhang W, Min M, Urba R . Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation. Sci Rep. 2024; 14(1):3577. PMC: 10861577. DOI: 10.1038/s41598-024-54197-4. View

17.

Wang Z, Luo J, Huang H, Wang L, Lv T, Wang Z . NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53/IRF1/type I interferon signaling axis. Cell Death Discov. 2024; 10(1):240. PMC: 11102450. DOI: 10.1038/s41420-024-01997-2. View

18.

Abbott M, Ustoyev Y . Cancer and the Immune System: The History and Background of Immunotherapy. Semin Oncol Nurs. 2019; 35(5):150923. DOI: 10.1016/j.soncn.2019.08.002. View

19.

Denisenko O . Epigenetics of Ribosomal RNA Genes. Biochemistry (Mosc). 2022; 87(Suppl 1):S103-S31. DOI: 10.1134/S0006297922140097. View

20.

Kong R, Zhang L, Hu L, Peng Q, Han W, Du X . hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem. 2010; 286(9):7139-48. PMC: 3044971. DOI: 10.1074/jbc.M110.173393. View